První polský případ smrtelné intoxikace cyklopropylfentanylem, novým syntetickým opioidem
Autori:
Pieprzyca Ewelina 1; Skowronek Rafał 1; Ska Korczy Małgorzata 1; Kulikowska Joanna 1; Czekaj Piotr 2
Pôsobisko autorov:
Department of Forensic Medicine and Forensic Toxicology, Medical University of Silesia in Katowice, Katowice, Poland
1; Department of Cytophysiology, Chair of Histology and Embryology, Medical University of Silesia in Katowice, Katowice, Poland
2
Vyšlo v časopise:
Soud Lék., 66, 2021, No. 3, p. 34-38
Kategória:
Súhrn
Prezentovaná práce popisuje první případ smrtelné intoxikace derivátem fentanylu, konkrétně cyclopropylfentanylem v Polské republice, jehož obětí byl 37letý muž. Tento opioid byl prokázán v biologickém materiálu odebraném během soudně lékařské pitvy a ve stříkačce nalezené poblíž zemřelého. Krev a moč zemřelého byly analyzovány metodou kapalinové chromatografie s hmotnostní spektrometrií. V krvi zemřelého byla zjištěna koncentrace cyklopropylfentanylu 24 ng/ml a v jeho moči 73 ng/ml. Případ úmrtí byl uzavřen jako smrtelná intoxikace jedinou látkou - cyklopropylfentanylem s náhlým udušením ucpáním dýchacích cest. Z popsaného případu vyplývá, že cyklopropylfentanyl je další syntetický opioid, který ohrožuje životy jeho uživatelů, a proto vyžaduje neustálé sledování a další studie.
Klíčová slova:
opioidy – analogy fentanylu – cyklopropylfentanyl – nové psychoaktivní látky (NPS)
Zdroje
1. European Monitoring Centre for Drugs and Drug Addiction (2019) European Drug Report: Trends and Developments, accessed March 17, 2020. http://www.emcdda.europa.eu/system/ files/publications/11364/20191724_TDAT- 19001PLN_PDF.pdf.
2. Zawilska JB. An Expanding World of Novel Psychoactive Substances: Opioids. Fron. Psychiatry 2017; 8: 110.
3. Armenian P, Vo KT, Barr-Walker J, Lynch KL. Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review. Neuropharmacology 2018; 134: 121-132.
4. Maher S, Elliott SP, George S. The analytical challenges of cyclopropylfentanyl and crotonylfentanyl: An approach for toxicological analysis. Drug Test Anal 2018; 10: 1483–1487.
5. Mallette JR, Casale JF, Hays PA. Characterization and differentiation of cyclopropylfentanyl from E-crotonylfentanyl, Z-crotonylfentanyl, and 3-butenylfentanyl. Sci Justice 2019; 59: 67-74.
6. Cyclopropylfentanyl, EMCDDA–Europol Joint Report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl] cyclopropanecarboxamide (cyclopropylfentanyl), accessed June 28, 2019. http://www. emcdda.europa.eu/system/files/publications/ 7926/20181014_TDAS18001ENN_PDF. pdf.
7. Janssen PAJ. 1-aralkyl-4-(n-aryl-carbonylamino)- piperidines and related compounds. January 5, 1965, accessed June 28, 2019. https:// www.google.com/patents/US3164600.
8. European Monitoring Centre for Drugs and Drug Addiction (2018), Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl) piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) in the framework of the Council Decision on new psychoactive substances, Risk Assessments, Publications Office of the European Union, Luxembourg, accessed June 28, 2019. https://www.emcdda.europa. eu/system/files/publications/9607/Risk%20 assessment%20cyclopropylfentanyl.pdf.
9. World Health Organization Critical Review Report: CYCLOPROPYLFENTANYL, accessed June 28, 2019. https://www.who.int/medicines/ access/controlled-substances/Cyclopropylfentanyl. pdf.
10. Fogarty M, Papsun D, Logan B. Analysis of Fentanyl and 18 Novel Fentanyl Analogs and Metabolites by LC–MS-MS, and report of Fatalities Associated with Methoxyacetylfentanyl and Cyclopropylfentanyl. J Anal Toxicol 2018; 42: 592–604.
11. Skowronek R, Pieprzyca E, Korczyńska M, Kulikowska J. “New” synthetic opioids in medicolegal practice – experiences from the Upper Silesia in Poland. Prz Lek 2017; 74: 512- 515.
12. https://hyperreal.info/talk/maf-metoxy-acetyl- fentanyl-t55810-90.html, accessed June 28, 2019.
13. Müller D, Neurath H, Neukamm MA, et al. New synthetic opioid cyclopropylfentanyl together with other novel synthetic opioids in respiratory insufficient comatose patients detected by toxicological analysis. Clin Toxicol 2019; 57: 806-812.
14. Zawadzki M, Nowak K. Fentanyl and its derivatives as a group of new psychoactive substances (designer drugs), Postepy Hig Med Dosw (online) 2018; 72: 547-556.
15. Wilde M, Pichini S, Pacifici R, et al. Metabolic Pathways and Potencies of New Fentanyl Analogs. Front Pharmacol 2019; 10: 238.
16. Vikingsson S, Rautio T, Wallgren J, et al. LC QTOF MS identification of major urinary cyclopropylfentanyl metabolites using synthesized standards. J Anal Toxicol 2019; 43: 607-614.
17. Seymour C, Shaner R, Feyereisen M, et al. Determination of fentanyl analog exposure using dried blood spots with LC-MS-MS. J Anal Toxicol 2019; 43: 266-276.
18. Bergh MS, Bogen IL, Wohlfarth A, Wilson SR, Øiestad ÅML. Distinguishing between cyclopropylfentanyl and crotonylfentanyl by methods commonly available in the forensic laboratory. Ther Drug Monit 2019; 41: 519-527.
19. Lee J, Krotulski AJ, Fogarty M, Papsun D, Logan B. Chromatographic separation of the isobaric compounds cyclopropylfentanyl, crotonylfentanyl, methacrylfentanyl, and para-methylacrylfentanyl for specific confirmation by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2019; 1118-1119: 164- 170.
20. Busardò FP, Carlier J, Giorgetti R, et al. Ultra-High-Performance Liquid Chromatography- Tandem Mass Spectrometry Assay for Quantifying Fentanyl and 22 Analogs and Metabolites in Whole Blood, Urine, and Hair. Front Chem 2019; 7: 184.
21. Guerrieri D, Kjellqvist F, Kronstrand R, Gréen H. Validation and Cross-Reactivity Data for Fentanyl Analogs With the Immunalysis Fentanyl ELISA. J Anal Toxicol 2019; 43: 18–24.
22. Cutler C, Hudson S. In vitro metabolism of the novel synthetic opioid agonist cyclopropylfentanyl and subsequent confirmation in authentic human samples using liquid chromatography- high resolution mass spectrometry. Drug Test Anal 2019; 11: 1134-1143.
23. Wilde M, Sommer MJ, Auwärter V, Hermanns- Clausen M. Acute severe intoxication with cyclopropylfentanyl, a novel synthetic opioid. Toxicol Lett 2020; 320: 109-112.
24. Drug Enforcement Administration (DEA), Drug and Chemical Evaluation Section, Diversion Control Division (2017), Cyclopropyl fentanyl: Background information and evaluation of ‘three factor analysis’ (factors 4, 5, and 6) for temporary scheduling, Springfield, VA, October 2017, accessed June 28, 2019. https://www.regulations.gov/document? D=DEA-2017-0013-0003.
25. Brockbals L, Staeheli SN, Gentile S, et al. Fatal poisoning involving cyclopropylfentanyl - Investigation of time-dependent postmortem redistribution. Forensic Sci Int 2019; 294: 80-85.
26. Fagiola M, Hahn T, Avella J. Five postmortem case reports with qualitative analysis of cyclopropylfentanyl by LC–MS-MS. J Anal Toxicol 2018; 43: e1-e6.
Štítky
Anatomical pathology Forensic medical examiner ToxicologyČlánok vyšiel v časopise
Forensic Medicine
2021 Číslo 3
Najčítanejšie v tomto čísle
- Aspects of forensic entomology in forensic medicine
- The extension, importance and function of eponymous terms in forensic medicine
- First Polish case of fatal single-substance poisoning with cyclopropylfentanyl, a new synthetic opioid
- MUDr. Josef Pleskot